These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29129878)
21. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer. Zhang HH; Li AH Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186 [TBL] [Abstract][Full Text] [Related]
22. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer. Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618 [TBL] [Abstract][Full Text] [Related]
23. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. Zhang W; Hou T; Niu C; Song L; Zhang Y PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519 [TBL] [Abstract][Full Text] [Related]
24. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer. Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975 [TBL] [Abstract][Full Text] [Related]
25. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961 [TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Luo M; Shen D; Wang W; Xian J Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer. Fan Y; Nan Y; Huang J; Zhong H; Zhou W Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29720427 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Kim HJ; Lee DW; Yim GW; Nam EJ; Kim S; Kim SW; Kim YT Int J Oncol; 2015 Feb; 46(2):521-30. PubMed ID: 25405331 [TBL] [Abstract][Full Text] [Related]
29. The long non-coding RNA HOTAIR increases tumour growth and invasion in cervical cancer by targeting the Notch pathway. Lee M; Kim HJ; Kim SW; Park SA; Chun KH; Cho NH; Song YS; Kim YT Oncotarget; 2016 Jul; 7(28):44558-44571. PubMed ID: 27323817 [TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. Yang M; Zhai X; Xia B; Wang Y; Lou G Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer. Zhang J; Lin Z; Gao Y; Yao T J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015 [TBL] [Abstract][Full Text] [Related]
32. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Gong J; Zhang H; He L; Wang L; Wang J Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810 [TBL] [Abstract][Full Text] [Related]
33. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients. Fang H; Shuang D; Yi Z; Sheng H; Liu Y Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer. Hong L; Chen W; Wu D; Wang Y Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922 [TBL] [Abstract][Full Text] [Related]
35. Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer. Shan S; Li HF; Yang XY; Guo S; Guo Y; Chu L; Xu MJ; Xin DM Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):507-512. PubMed ID: 30720157 [TBL] [Abstract][Full Text] [Related]
36. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer. Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253 [TBL] [Abstract][Full Text] [Related]
38. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer. Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741 [TBL] [Abstract][Full Text] [Related]
39. Long non‑coding nuclear paraspeckle assembly transcript 1 acts as prognosis biomarker and increases cell growth and invasion in cervical cancer by sequestering microRNA‑101. Wang L; Zhu H Mol Med Rep; 2018 Feb; 17(2):2771-2777. PubMed ID: 29207151 [TBL] [Abstract][Full Text] [Related]
40. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer. Xu R; Hu J; Zhang T; Jiang C; Wang HY Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]